Human strongyloidiasis: complexities and pathways forward

D Buonfrate, RS Bradbury, MR Watts… - Clinical Microbiology …, 2023 - Am Soc Microbiol
SUMMARY Strongyloidiasis is a World Health Organization neglected tropical disease
usually caused by Strongyloides stercoralis, a parasitic worm with a complex life cycle …

[HTML][HTML] The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

L Caly, JD Druce, MG Catton, DA Jans, KM Wagstaff - Antiviral research, 2020 - Elsevier
Although several clinical trials are now underway to test possible therapies, the worldwide
response to the COVID-19 outbreak has been largely limited to monitoring/containment. We …

Strongyloides stercoralis

JM Czeresnia, LM Weiss - Lung, 2022 - Springer
Strongyloidiasis has been estimated to affect over 600 million people worldwide. It is caused
by Strongyloides stercoralis, a roundworm endemic to the tropics and subtropics, especially …

The global progress of soil-transmitted helminthiases control in 2020 and World Health Organization targets for 2030

A Montresor, D Mupfasoni, A Mikhailov… - PLoS neglected …, 2020 - journals.plos.org
Soil-transmitted helminth (STH) infections are the most widespread of the neglected tropical
diseases, primarily affecting marginalized populations in low-and middle-income countries …

[HTML][HTML] Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients

D Camprubí, A Almuedo-Riera, H Martí-Soler… - PloS one, 2020 - journals.plos.org
Ivermectin has recently shown efficacy against SARS-CoV-2 in-vitro. We retrospectively
reviewed severe COVID-19 patients receiving standard doses of ivermectin and we …

Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia

V Marchese, V Crosato, M Gulletta, F Castelnuovo… - Infection, 2021 - Springer
Background SARS-CoV-2 pandemic has posed formidable public health and clinical
challenges. The use of immunosuppressive agents, such as high dose corticosteroids and …

Turning the tide: Natural products and natural-product-inspired chemicals as potential counters to SARS-CoV-2 infection

Z Wang, L Yang - Frontiers in Pharmacology, 2020 - frontiersin.org
The novel and highly pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), which causes coronavirus disease 2019 (COVID-19), has become a continued …

Strongyloides stercoralis: A Neglected but Fatal Parasite

V Luvira, T Siripoon, D Phiboonbanakit… - Tropical Medicine and …, 2022 - mdpi.com
Strongyloidiasis is a disease caused by Strongyloides stercoralis and remains a neglected
tropical infection despite significant public health concerns. Challenges in the management …

RETRACTED: effects of a single dose of ivermectin on viral and clinical outcomes in asymptomatic SARS-CoV-2 infected subjects: a pilot clinical trial in Lebanon

AA Samaha, H Mouawia, M Fawaz, H Hassan… - Viruses, 2021 - mdpi.com
Objective: This study was designed to determine the efficacy of ivermectin, an FDA-
approved drug, in producing clinical benefits and decreasing the viral load of SARS-CoV-2 …

COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks

C Murugan, S Ramamoorthy, G Kuppuswamy… - International journal of …, 2021 - Elsevier
Today, the world population is facing an existential threat by an invisible enemy known as
severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) or COVID-19. It is highly …